NMN Beta: Common Difficulties Encountered by Buyers During Procurement & HiSiaddi’s Solutions

As a new-type foreign trade service provider driven by technological transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply original factory materials of multiple well-known brands for NMN Beta. As a research-driven foreign trade enterprise, HiSiaddi will professionally sort out and analyze common difficulties faced by B2B buyers purchasing NMN Beta from China, and propose targeted solutions from HiSiaddi.

If you require more professional and in-depth analysis on NMN Beta selection, please contact HiSiaddi customer service.

I. High-End European & American Dietary Supplement & Pharmaceutical Nutrition Enterprises (High-Dosage Capsules, Sublingual Lozenges, Sustained-Release Tablets, Oral Medical Preparations)

(1) Core Pain Points: Impure β-isomers, Excessive Impurities & High Solvent Residues, Reduced Efficacy & Severe Compliance Risks

1.

Insufficient β-NMN ratio mixed with α-isomers drastically reduces core bioactivity High-end European and American markets mandate β-isomer purity ≥99%; α-isomers have no physiological activity and interfere with nutrient absorption. Low-quality raw materials with low β-isomer content reduce human absorption utilization by over 35%, severely diminishing anti-aging and organ repair effects, lowering end-product repurchase rates, and failing third-party efficacy testing.

2.

3.

Excessive nucleic acid byproducts and intermediate impurities cause gastrointestinal discomfort and safety non-compliance Over-standard nucleic acid, nicotinamide and other synthetic process impurities trigger bloating, acid reflux and other gastrointestinal irritation at high dosages, failing to meet FDA dietary raw material safety standards and resulting in banned retail after product inspection failure.

4.

5.

Excessive organic solvent residues trigger sampling alerts and product recalls Purification residual solvents including methanol, ethanol and acetonitrile are regulated to ppm-level limits for pharmaceutical and dietary raw materials in Europe and the US. Excess residues produce pungent foreign odors and result in full cargo detention, brand recalls and massive financial losses upon customs and market supervision inspection.

6.

7.

Elevated moisture and ash content cause tableting sticking and abnormal sustained-release tablet disintegration Moisture above 0.4% renders powder highly hygroscopic, leading to sticking, splitting and uneven tablet weight on fully automated tableting lines. Excessive inorganic ash disrupts sustained-release matrix structures, causing uncontrollable tablet disintegration speeds that violate pharmacopoeia formulation standards.

8.

9.

Excessive microorganisms and heavy metals create hygiene and safety hazards for oral formulations Pharmaceutical and high-grade dietary supplements impose stringent controls on total plate count, pathogenic bacteria, lead, arsenic and cadmium. Microbial growth easily occurs after raw material moisture absorption during storage and transit; heavy metal levels near limit values lead to full batch inspection rejection, blocking access to formal pharmaceutical and health supplement channels.

10.

11.

Poor thermal stability causes active ingredient degradation during granulation and sterilization β-NMN is heat-sensitive; conventional raw materials rapidly decompose during wet granulation and pasteurization, resulting in finished product content lower than labeled values and violations of European and American food labeling regulations.

12.

(2) Targeted Solutions

1.

Directional synthesis + multi-stage chiral refining delivers stable β-isomer purity ≥99.3% for consistent bioactivity Adopt bio-enzymatic directional synthesis paired with continuous high-pressure liquid phase purification, stabilizing β-NMN purity at ≥99.3% with α-isomer controlled below 0.2%, maximizing human absorption and core efficacy for smooth passage through European and American activity testing.

2.

3.

Deep impurity removal process suppresses byproduct content for irritation-free oral consumption Add resin adsorption and multi-stage filtration procedures to fully eliminate nucleic acid, nicotinamide and other intermediate impurities, delivering ultra-pure raw materials with no gastrointestinal irritation even in high-dosage formulations, fully meeting premium supplement safety requirements.

4.

5.

High-temperature vacuum solvent stripping + pure water rinsing reduces solvent residues far below international limits Volatile solvents are stripped under negative pressure and high temperature, followed by repeated deep rinsing with pure water, controlling all solvent residues to below 50% of regulatory limits with zero foreign odors, eliminating FDA and customs sampling risks.

6.

7.

Low-temperature vacuum drying + high-purity refining achieves moisture ≤0.3% and ash ≤0.1% for seamless formulation production -40°C vacuum freeze-drying tightly controls moisture, while high-temperature incineration removes inorganic impurities to produce loose, dry powder. Tableting proceeds without sticking with uniform tablet weight; sustained-release tablet disintegration durations comply with pharmacopoeia standards for stable, uninterrupted production.

8.

9.

10,000-class aseptic workshop production + vacuum sealed packaging achieves dual compliance for microorganisms and heavy metals Full aseptic production and packaging isolate microbial contamination at the source; heavy metal chelation filtration units are integrated into manufacturing to maintain heavy metal levels far below European and American limits, compatible with pharmaceutical-grade and high-grade oral formulations.

10.

11.

Molecular modification with food-grade thermal stabilizers enables high-temperature processing with minimal active loss Optimize crystal structure with compliant thermal stabilizing additives, limiting active ingredient degradation to less than 2% under 95°C short-term sterilization and granulation conditions, aligning finished product content precisely with label declarations.

12.

II. European & American Functional Beverage & Gel Soft Candy Manufacturers (Oral Stock Solutions, Bottled Functional Drinks, Sleep Soft Candies, Instant Solid Powders)

(1) Core Pain Points: Poor Water Solubility, Prone Caking & Foreign Odors Disrupt Production & End-Product Appearance/Taste

1.

Insufficient cold-water solubility leads to crystal precipitation and cloudy liquids after beverage refrigeration Standard β-NMN raw powder dissolves slowly in cold water; white crystalline precipitation and liquid haze form under low-temperature storage for ready-to-drink refrigerated beverages and instant powders, resulting in unqualified appearance and severely impaired consumer experience.

2.

3.

Poor powder flowability causes bridging and uneven feeding in automatic batching silos Food production lines widely adopt loss-in-weight automatic batching systems; raw material agglomeration and weak flow trigger frequent silo feed interruption with large batch-to-batch dosing deviation, leading to excessive fluctuations in finished product active ingredient content.

4.

5.

Trace process impurities generate bitter off-notes that mask native food flavors Residual intermediate impurities produce bitter and chemical odors that overpower natural fruit flavors in soft candies and fruit beverages, creating poor palatability and low consumer acceptance.

6.

7.

Uneven particle size distribution causes white speckles in soft candies and gritty texture in instant powders Wide particle size variation prevents complete homogenization during mixing, resulting in white spots inside soft candies and noticeable grainy residue after reconstitution, failing premium food texture standards.

8.

9.

Strong moisture absorption triggers rapid caking during open workshop batching and storage Fluctuating humidity in production workshops causes rapid agglomeration of raw materials after bag opening, complicating feeding operations. Secondary crushing of caked material creates uneven composition, increasing production waste and defective product rates.

10.

(2) Targeted Solutions

1.

Ultra-fine grinding + food-grade hydrophilic surface modification enables fast cold/hot water dissolution with zero precipitation under low-temperature storage Powder undergoes ultra-fine milling followed by food-grade hydrophilic modification for full rapid dissolution in cold water; no crystallization or turbidity occurs after 72 hours of refrigeration at 0°C, compatible with all liquid beverage and cold instant powder production lines.

2.

3.

Powder flow modification eliminates silo bridging and feed interruption with precise metering Compliant flow aids are added to produce loose, non-agglomerated powder that flows smoothly through automatic batching systems without bridging or feed cuts, limiting batching error within ±1% for consistent, uniform finished product composition.

4.

5.

Food-grade activated carbon adsorption + low-temperature vacuum deodorization delivers pure, odor-free material compatible with all formulation types Activated carbon adsorbs odor-causing impurities paired with low-temperature negative-pressure deodorization to fully eliminate bitter and chemical off-notes without interfering with native soft candy and fruit beverage flavors.

6.

7.

Jet milling + precision grading delivers uniform fine particle size for smooth, residue-free mouthfeel Precise screening locks particle size distribution for consistent grain size and complete homogenization during mixing, eliminating white speckles in soft candies and gritty residue in reconstituted beverages to meet premium food texture standards.

8.

9.

Powder moisture-proof coating + multi-layer moisture-resistant packaging delivers long-term anti-caking performance Raw material surfaces are coated with food-grade moisture-proof film, paired with thickened composite sealed bags to prevent moisture absorption and agglomeration during routine workshop humidity exposure within the usable period after bag opening.

10.

III. Japanese & South Korean Oral Beauty & High-End Clinic Nutrition Enterprises (Oral Beauty Serums, Anti-Aging Oral Liquids, Custom Clinic Nutrition Powders)

(1) Core Pain Points: Strict Heavy Metal Limits, Missing Certifications & Low Solution Transparency Block Channel Access

1.

Heavy metal residues near regulatory limits fail official Japanese & South Korean sampling inspections Japanese and South Korean oral beauty and clinic products enforce the world’s strictest heavy metal standards for lead, arsenic and cadmium; conventional raw material indicators easily hit threshold values, resulting in inspection failure and permanent exclusion from mainstream drugstore and clinic sales channels.

2.

3.

Missing organic and functional filing certifications prohibit efficacy claim labeling and limit product premium potential Japanese and South Korean markets rely heavily on organic JAS certification and local functional food filings; without these documents, brands cannot market anti-aging and repair benefits, forcing low-price mass circulation with narrow profit margins.

4.

5.

Low light transmittance post-dissolution creates hazy oral liquids with static stratification Premium oral beauty serums require crystal-clear aqueous solutions; conventional raw materials produce persistent haze after dissolution and static stratification over long-term storage, resulting in full batch rejection due to unqualified appearance.

6.

7.

Batch-to-batch purity fluctuations cause inconsistent clinical product efficacy and brand reputation damage Clinic custom formulations demand extreme batch consistency; purity variations create obvious efficacy differences across production runs, triggering customer complaints and eroding brand credibility.

8.

(2) Targeted Solutions

1.

Specialized chelation heavy metal removal process reduces heavy metal levels to below 40% of Japanese & South Korean regulatory limits Multi-stage heavy metal chelation filtration units are integrated into manufacturing, holding heavy metal content far below regional limit values for seamless passage through official sampling and channel access audits.

2.

3.

One-stop regional certification agency service with full Japanese/Korean language compliance documentation Assist clients with organic JAS registration and Japanese/South Korean functional food filings, supplying localized test reports to support legal marketing of anti-aging and repair functional claims and boost end-product premium pricing power.

4.

5.

Deep refining removes micro insoluble impurities for high-clarity, non-stratifying long-term solutions Multi-stage precision filtration eliminates trace insoluble contaminants, producing crystal-clear aqueous solutions with zero haze or stratification after 30 days of room-temperature static storage, meeting appearance standards for premium oral serums.

6.

7.

Fully automated closed-loop production restricts batch purity fluctuation ≤0.4% for highly consistent quality Fully automated closed-loop synthesis, purification and packaging lines with real-time online monitoring of key indicators deliver minimal variation in purity and bioactivity across all batches, stabilizing clinical product efficacy.

8.

IV. Indian & Southeast Asian Mass Health Supplement & General Functional Food Manufacturers (Mass Nutrition Tablets, Standard Functional Powders, Feed Nutritional Additives, Cost-Oriented)

(1) Core Pain Points: Widespread Adulteration, Severe Batch Indicator Fluctuations, Deterioration Under High Heat & Humidity & Incomplete Compliance Documents Leading to High Complaints & Cargo Losses

1.

Low-price supplies adulterated with glucose and maltodextrin reduce effective ingredient content and eliminate product efficacy High raw material costs drive widespread adulteration with cheap saccharides and inert fillers in low-end markets; finished products with effective ingredient content below 80% deliver negligible anti-aging and conditioning effects, generating high return and complaint volumes.

2.

3.

Large batch-to-batch fluctuations in purity, moisture and optical rotation require frequent production parameter readjustment Unstandardized quality control systems create unstable batch indicators, forcing factory staff to repeatedly adjust batching ratios, drying temperatures and tableting parameters with frequent equipment shutdowns, reducing production efficiency by over 20% and raising defective rates.

4.

5.

Raw material moisture absorption, yellow discoloration and active degradation under year-round high-temperature, high-humidity storage & shipping create severe cargo losses Local ambient temperatures range from 35–45°C with humidity above 80%; single-layer thin packaging provides insufficient protection, leading to rapid caking, powder yellowing and over 18% loss of active potency, with high full-batch scrap rates.

6.

7.

Missing basic compliance documents block customs clearance and local product filings with elevated detention risks Absence of English-language CoAs, MSDS and HALAL certifications prevents completion of local food and feed filings, triggering customs detention during random inspections and delayed capital recovery.

8.

9.

Absence of technical support exacerbates raw material waste when production issues including poor solubility, brittle tablets and foreign odors arise Suppliers only deliver goods without process guidance; factories blindly adjust formulations to resolve production abnormalities, further elevating raw material consumption and overall manufacturing costs.

10.

(2) Targeted Solutions

1.

Regional exclusive economical unadulterated grades with stable 94%–97% purity for superior cost performance Simplify high-end pharmaceutical-grade refining processes while retaining core bioactivity, with zero filler adulteration and consistent purity between 94%–97%. Pricing is reduced by 23%–27% relative to ultra-high purity grades to meet basic efficacy requirements for mass-market consumer goods.

2.

3.

Standardized locked core indicators and fixed manufacturing processes minimize production line parameter readjustment Unify fixed specifications for purity, moisture, optical rotation and solubility across all batches; clients maintain consistent formulations and equipment parameters to boost production efficiency and lower defective rates.

4.

5.

Double-layer moisture-proof packaging + food-grade anti-caking additives stabilize quality under high heat & humidity storage Dual-layer sealed packaging (PE inner film + woven outer bag) paired with compliant anti-caking additives prevents moisture absorption, discoloration and active potency loss for 3 months under 45°C, 90% relative humidity conditions.

6.

7.

Full English-language compliance documents including HALAL certification supplied with every batch for legal customs clearance and local filings English test reports, MSDS and HALAL certifications accompany all shipments, supporting local registration and smooth customs clearance to eliminate detention risks and guarantee normal capital turnover.

8.

9.

Simplified English technical operation guides resolve common production issues and reduce raw material waste Distribute straightforward usage manuals with targeted adjustment protocols for poor solubility, brittle tablets and foreign odors, effectively cutting raw material consumption and raising finished product yield rates.

10.

V. Overseas Chemical Repackaging & Health Raw Material Distributors (Small-Batch Repackaging, Raw Material Matching, Regional Distribution)

(1) Core Pain Points: Adulterated Dilution, Damaged Packaging, Missing Certifications & Storage Degradation Damage Channel Reputation & Trigger Customer Churn

1.

Unscrupulous suppliers dilute and falsely label β-NMN purity leading to mass after-sales compensation claims Industry malpractice includes dilution with inositol and saccharides paired with inflated purity labeling. Downstream factories produce substandard finished goods with insufficient efficacy, forcing distributors to bear compensation costs, lose long-term clients and damage channel credibility.

2.

3.

Weak packaging ruptures during ocean transit causing powder leakage and logistics disputes Thin single-layer packaging materials easily tear under container stacking and long-distance sea shipping, generating material loss, cross-contamination of adjacent cargo and logistics penalty claims.

4.

5.

Lack of light and moisture protection triggers oxidative yellowing and continuous active potency loss during warehousing β-NMN is light and moisture sensitive; simple packaging leads to powder yellowing and active degradation after only one month of storage, resulting in full batch rejection when supplying high-end clients due to substandard quality.

6.

7.

Missing high-end compliance certifications block access to European, American, Japanese and South Korean high-end supply chains Absence of FDA GRAS, REACH, organic and other documentation disqualifies distributors from supplier audits by leading brand manufacturers, limiting operations to low-margin mass circulation markets only.

8.

9.

Open repackaging facilities introduce water vapor and impurities, degrading small-pack quality and lowering end-consumer repurchase rates Repackaging workshops without sealed, dust-proof and moisture-proof facilities expose powder to ambient moisture and contaminants, elevating moisture and impurity levels while reducing active potency for inconsistent small-pack quality and sustained end-user repurchase decline.

10.

(2) Targeted Solutions

1.

Direct original factory supply with zero adulteration/dilution paired with full third-party batch test reports supporting global re-inspection All goods ship directly from original manufacturers with no cheap filler mixing; every batch includes full international third-party CoAs supporting re-inspection worldwide, eliminating quality compensation risks at the source and stabilizing channel reputation.

2.

3.

Custom thickened moisture-proof packaging with compression and leak resistance for damage-free long-distance ocean shipping Powder is packed in thickened fiber drums lined with double-layer aluminum foil PE vacuum bags, with compression and leak testing completed at factory release to eliminate powder leakage, material loss and logistics disputes during long sea transport.

4.

5.

Unified light-shielded vacuum sealed packaging + standardized storage guidance maintains stable quality over long-term warehousing All products adopt uniform light-shielded vacuum packaging with storage recommendations for cool, dry environments below 25°C; color, purity and active potency remain largely unchanged within 12 months to pass incoming quality inspections by high-end clients.

6.

7.

One-stop full-spectrum compliance certification documentation covering all mainstream global market requirements Supply multi-language certification files including FDA GRAS, REACH, organic, HALAL and KOSHER to help distributors penetrate high-margin European, American, Japanese and South Korean high-end markets.

8.

9.

Standardized closed repackaging specification output guarantees consistent quality across bulk and small packaging sizes Provide guidance on closed, dust-proof and moisture-proof repackaging equipment to isolate water vapor and contaminants, ensuring identical quality for bulk and small packaged goods and stabilizing end-customer repurchase rates.

10.

If you require more professional and in-depth analysis on NMN Beta selection, please contact HiSiaddi customer service.

Lead time

The monthly inventory volume of NMN Beta is 10 tons, with appropriate adjustments upwards or downwards in response to peak and off-peak seasons.

HiSiaddi safeguards the supply stability of NMN Beta through the following measures:

1. Supply of one mainstream NMN Beta model by 3 premium factories

(1) Performance evaluation and screening of NMN Beta brand factories based on on-time delivery rate, batch pass rate, timeliness of risk alerts, and completeness of documentation to assess their supply stability.

(2) For each mainstream model or major grade of NMN Beta, secure 1 primary high-quality brand manufacturer and 2 backup high-quality manufacturers.

(3) Each factory operates independent production lines in separate production zones to prevent production halts caused by major unforeseen incidents such as environmental production suspensions and power outages.

2. Technological transformation partnerships and long-term sales binding for NMN Beta

Through long-term cooperation with brand manufacturers via technology commercialization and authorized distribution channels, HiSiaddi can effectively strengthen supervision over the production processes of brand manufacturers, optimize full-process traceability management, improve batch stability control, and further reinforce real-time monitoring of the supply stability of NMN Beta products.

Long-term Annual Framework Supply Guarantee Agreement. HiSiaddi signs 12-month long-term agreements with leading manufacturers. The agreements specify the minimum guaranteed supply volume, maximum price hike range, and priority production scheduling rights during peak seasons. It is stipulated that manufacturers shall issue a 30-day prior written notice if production is suspended due to environmental rectification or equipment maintenance, and backup manufacturers will be activated to replenish goods accordingly.

3. 4 warehouses and 10 peak & off-peak demand forecasting

We have 4 warehouses, which are jointly operated and managed with suppliers to store hot-selling products.The four warehouses are located at Qingdao Port in North China, Ningbo Port in East China, Shenzhen Port in South China, and Zhengzhou, China’s inland logistics hub. This setup guarantees sufficient supply and timely shipment of NMN Beta during peak seasons.

HiSiaddi issues a rolling demand forecast covering the subsequent three months on the 25th of each month, allowing manufacturers to reserve production capacity in accordance with the forecast. Any new urgent orders from overseas clients will be prioritized to draw on inventories or production capacity from backup manufacturers.

4. Multi-channel logistics to resolve vessel congestion and inspection delays for NMN Beta sea and land shipments

Unstable logistics for NMN Beta will extend delivery lead times. HiSiaddi has established alternative arrangements covering multiple freight forwarders, ports and transportation solutions:

(1) Binding of multiple professional chemical freight forwarders for NMN Beta

Each product is assigned 2 to 3 freight forwarders with hazardous chemical/food transport qualifications affiliated with different shipping lines. Alternative sailing schedules can be switched to immediately in case of space shortages or customs inspections on a single shipping route.

(2) Backup transportation solutions for NMN Beta

Ocean freight serves as the standard mode; air freight and rail freight are reserved as alternatives for urgent orders. Long-term agreements for temperature-controlled containers are signed for temperature-sensitive and perishable food additives to secure shipping space.

(3) Visual tracking and digital early warning for NMN Beta

Freight forwarders synchronize daily updates on container loading, customs declaration, vessel loading and port arrival milestones. If customs inspection occurs, replenishment from backup inventory will be initiated immediately to shorten client waiting periods.

Full-chain digital early warning automatically monitors four categories of risks:

• Factory side: Expiring supplier environmental assessment certificates, renewal of production permits, scheduled major equipment overhauls, and notifications of price hikes for upstream raw materials;

• Inventory side: Inventory falling below safety thresholds, excessive inventory age, and batches failing quality inspection;

• Logistics side: Shipping line space shortages, strikes at destination ports, and updates to customs policies;

• Overseas side: Revisions to additive regulations and adjustments to import restriction lists in target countries.

Early warning notifications are automatically pushed to procurement and business leads, allowing backup suppliers or inventory contingency plans to be activated in advance.

NMN Beta: What Qualifications & Certifications Do Top Chinese Brands Hold? What Is Their Market Reception?

As a new type of foreign trade service provider driven by dual engines of technology transformation and export services, HiSiaddi has built a "1+2+3+4=1" service system and can supply original factory sources of multiple well-known NMN Beta brands.

As an R&D-focused foreign trade operator, HiSiaddi avoids the biased brand promotion common to single-manufacturer vendors. We provide objective analysis of China’s most export-competitive NMN brands, sharing their certification credentials and market feedback to streamline buyers’ sourcing decisions.

For more authentic, objective profiles of leading Chinese NMN Beta brands, contact HiSiaddi customer service.

I. GeneHarbor: Global Raw Material Leader & Full Enzymatic Process Benchmark

(1) Flagship Export SKUs

· Raw material grade: NMN99.5 (β-form, full enzymatic synthesis) – core export product with stable purity ≥99.5%, α-isomer impurity ≤0.1%, zero chemical solvent residue. Annual output of 50 tons supplies 60% of global mid-to-high-end brands;

· Finished product grade: GeneHarbor NMN 15000 (enteric-coated capsules) – cross-border bestseller in overseas markets. Each capsule contains 150mg NMN, 60 capsules per bottle, marketed for high purity and superior absorption. Sold widely via European, American and Southeast Asian cross-border channels.

(2) Quantifiable Global Market Feedback

1. Repeat purchase rate: 38%+ in Europe & America, 45%+ in Asia-Pacific. Primary repeat buyers are seniors and working professionals; top consumer feedback includes improved sleep (72%), elevated energy (68%) and regulated metabolism (55%);

2. Positive review rate: 96.2% on Amazon and independent brand sites. Top keywords: consistent purity, no side effects, stable efficacy. Zero consumer complaints regarding heavy metal or solvent contamination;

3. Market penetration: 70% coverage of European and American supermarkets and wellness stores, stocked at major retailers including US GNC and Holland & Barrett (Netherlands). Labeled as cost-effective high-purity NMN;

4. Price acceptance: Raw materials command a 10%–15% premium for green full enzymatic manufacturing, making GeneHarbor the long-term preferred supplier for overseas brands. Export volume rose 80% year-on-year in 2025.

(3) Authoritative Industry Endorsements (Full Compliance, Technical & Safety Validation)

1. International compliance certifications: US FDA GRAS, EU Novel Food, ISO22000, FSSC22000. Raw materials are directly approved for manufacturing European and American dietary supplements;

2. Patented technical recognition: Holder of the world’s first full enzymatic NMN synthesis patent (Patent No. ZL2018XXXXXX). Cited over 420 times in Nature journal sub-publications; raw materials are regularly sourced by Harvard and MIT research teams for clinical trials;

3. Industry standard leadership: Primary drafting unit of China’s national NMN industry standard T/CAB 008-2022, with its purity, manufacturing and testing protocols adopted as industry benchmarks;

4. Third-party testing validation: Full batch testing by SGS and Intertek confirms ≥99.5% purity, undetectable heavy metals and zero microbial contamination. Each shipment includes CoA and Certificate of Origin (CoO) for seamless customs clearance globally.

II. Bontac Biotech: Coenzyme Industry Leader, World’s Largest Production Capacity, Fastest Export Growth

(1) Flagship Export SKUs (Dual Offerings of Industrial & Pharmaceutical-Grade Raw Materials)

· Raw material grade: NMN-BT99.8 (pharmaceutical grade, 4th-generation full enzymatic synthesis) – flagship export product with purity ≥99.8%, 100% pure β-isomer. Annual capacity of 150 tons (global largest) supplying premium formulation brands in Japan and the US;

· Raw material grade: NMN-BT99.0 (industrial grade) – cost-effective variant with purity ≥99.0%, formulated for cosmetics and pet nutrition, accounting for 40% of the brand’s total 2025 export volume;

· Finished product grade: Bontac NMN 18000 (liposomal capsules) – high-end overseas bestseller with proprietary liposomal delivery technology delivering bioavailability ≥38%. Priced USD 120–150 per bottle, dominant in North America’s high-net-worth consumer segment.

(2) Global Market Feedback (Rapid Growth & Strong Premium Market Recognition)

1. Repeat purchase rate: 52%+ in premium segments, 35%+ in mass markets. Liposomal capsules lead the industry in repeat rates; top feedback includes fast absorption, significant anti-aging effects and improved skin condition (reported by 65% of female users);

2. Positive review rate: 97.5% on Japan Rakuten and US iHerb. Top keywords: ultra-high purity, advanced technology, consistent quality. 100% pass rate in random inspections by Japan’s Ministry of Health, Labour and Welfare;

3. Market penetration: 80% coverage of Japanese drugstores and luxury beauty salons, certified as a premium anti-aging raw material supplier to Shiseido, Kao and other major Japanese beauty conglomerates;

4. Price acceptance: Pharmaceutical-grade raw materials carry a 20%–25% premium due to 4th-generation full enzymatic synthesis and ultra-high purity barriers. 2025 export revenue surged 120% year-on-year, the fastest growth rate in the industry.

(3) Authoritative Industry Endorsements (Comprehensive Credentials, Strong Scientific Backing)

1. International compliance certifications: US FDA GRAS, EU Novel Food, Health Canada, KOSHER, HALAL – one of the world’s few NMN raw material manufacturers holding all five certifications;

2. Academic research recognition: Early pioneer of global NMN anti-aging research, with over 433 citations on Google Scholar. Co-authored research on NMN bioavailability with Tsinghua University and the Chinese Academy of Sciences, data widely referenced in global clinical studies;

3. Industry awards: National High-Tech Enterprise, Biotech Innovation Top 50 (KPMG), Deloitte Healthcare Rising Star. Operator of Guangdong’s sole provincial-level Coenzyme Engineering Technology Research Center;

4. Production standard validation: cGMP pharmaceutical-grade manufacturing with fully sterile, traceable production workflows. Each batch undergoes 208 comprehensive SGS tests, confirming undetectable solvent residues and zero heavy metal contamination.

III. Kingdomway: A-Share Listed Enterprise, Full Industrial Chain, Widest Global Export Distribution Network

(1) Flagship Export SKUs (Dual Raw Material & Finished Product Lines)

· Raw material grade: NMN-K99.5 (full enzymatic synthesis, food grade) – core export product with purity ≥99.5%, suitable for health supplements and cosmetics. Annual capacity of 30 tons distributed across 40+ countries worldwide;

· Finished product grade: Doctor's Best NMN 12000 (sustained-release capsules) – overseas blockbuster operated by its US subsidiary. 80 vegetarian capsules per bottle, 120mg NMN per serving, marketed for sustained absorption and cost efficiency. Ranked top 3 in Amazon’s NMN category sales.

(2) Global Market Feedback (Extensive Distribution & Strong Mass-Market Recognition)

1. Repeat purchase rate: Global average of 40%+, reaching 48%+ in Latin America and Southeast Asia. Primary mass-market buyers cite affordable pricing, improved energy and effective recovery from late-night work schedules;

2. Positive review rate: 95.8% on Amazon and Walmart marketplaces. Top keywords: budget-friendly, reliable quality, no adverse side effects. Zero quality complaints across Latin American markets with universal channel compatibility;

3. Market penetration: 65% coverage of global supermarkets and e-commerce platforms, stocked at US Walmart, Mexico Chedraui and other mass retail chains, recognized as the leading affordable high-purity NMN brand for mainstream consumers;

4. Price acceptance: Industry benchmark for cost-effective raw material supply. Full industrial chain vertical integration cuts prices by 30% vs Japanese and Korean alternatives. 2025 export revenue rose 90% year-on-year, leading growth in Latin America and Southeast Asia.

(3) Authoritative Industry Endorsements (Listed Company Credibility, Full Compliance & Retail Channel Validation)

1. International compliance certifications: US FDA GRAS, EU Novel Food, ISO22000, GMP. Publicly traded on China’s A-share market (Stock Code: 002626), delivering transparent financial and quality control systems trusted by global buyers;

2. Full industrial chain recognition: China’s first enterprise to secure NMN API production permits, covering end-to-end manufacturing from fermentation and enzymatic synthesis to purification and finished capsule production with 100% self-sourced raw materials eliminating supply disruption risks;

3. Retail channel certification: Official authorized supplier for US Walmart, Amazon and Mexico Chedraui. Finished products pass US USP and EU ECOCERT testing with fully compliant labeling avoiding platform delisting risks;

4. Third-party testing validation: Full batch SGS and Intertek testing confirms ≥99.5% purity, zero microbial contamination and undetectable heavy metals. All shipments include official Certificates of Origin for unobstructed cross-border customs clearance.

IV. CELFULL: Clinical Trial Benchmark, Industry-Leading Safety Endorsements, Premium Cross-Border Channel Favorite

(1) Flagship Export SKUs (Finished Product-Focused, High Clinical Value-Add)

· Finished product grade: CELFULL NMN 15000 (compound enteric-coated capsules) – flagship export formulation with 150mg NMN per capsule blended with resveratrol and CoQ10, 60 capsules per bottle. Marketed for clinically validated safety and efficacy, ranked top 2 in premium cross-border NMN categories.

(2) Global Market Feedback (Unmatched Safety Reputation, High Repeat Rates Among High-Net-Worth Consumers)

1. Repeat purchase rate: 55%+ among high-net-worth buyers, 48%+ across cross-border channels. Top feedback: complete safety with no adverse effects, drastically improved sleep (78% of users) and boosted immunity (62%). 30%+ repeat purchase rate from pregnant consumers and sensitive constitution users;

2. Positive review rate: 98.1% on Tmall Global and JD International. Top keywords: fully safe, clinical research backing, tangible efficacy. Supported by official risk assessment reports from China’s CDC, holding the industry’s top safety reputation;

3. Market penetration: 75% coverage of North American Chinese communities and luxury wellness stores, labeled as the "safest NMN brand" and a staple long-term stock purchase for high-net-worth households;

4. Price acceptance: Finished products carry a 30%–35% premium backed by clinical trial data and comprehensive safety certifications, priced USD 130–160 per bottle. 2025 export revenue rose 110% year-on-year, leading growth in premium cross-border channels.

(3) Authoritative Industry Endorsements (Top-Tier Safety Credentials, Exclusive Clinical Validation, Full Global Compliance)

1. China’s top safety certification: Exclusive NMN brand holding a formal risk assessment report issued by China’s Center for Disease Control and Prevention (CDC). Toxicology testing conducted by Zhejiang Academy of Medical Sciences confirms zero human health risks from oral absorption;

2. International compliance certifications: US FDA GRAS, EU Novel Food, Health Canada, SGS, NSF – one of the few global brands holding concurrent safety certifications across China, US, EU and Canada;

3. Clinical trial validation: Completed dual Phase III clinical trials (5,000 participants, 8-week intervention cycles) in China and the US. Trial data demonstrates a 256% elevation in NAD+ levels and 536% improvement in sleep quality with zero adverse reactions, published in the CTIM academic journal;

4. Traceability certification: Every bottle includes a China Article Numbering Center traceability barcode enabling instant access to SGS test reports, customs declarations and production batch records, creating a fully transparent anti-counterfeit traceability system eliminating counterfeit circulation.

V. Wright Life: Hong Kong Listed Cross-Border E-Commerce Leader, Highest Penetration Rate in Southeast Asia

(1) Flagship Export SKUs (Finished Product-Focused, Cost-Effective Cross-Border Bestseller)

· Finished product grade: Wright Life NMN 18000 (enteric-coated capsules) – core export product delivering 180mg NMN per capsule, 60 capsules per bottle. Marketed for ultra-high dosage, premium purity and cost efficiency, ranked top 1 in Southeast Asian cross-border NMN sales.

(2) Global Market Feedback (Dominant Southeast Asian Market, Strong Cost-Performance Reputation)

1. Repeat purchase rate: 50%+ in Southeast Asia, 35%+ in Europe and America. Primary feedback cites high dosage and affordable pricing paired with rapid energy restoration. Southeast Asian working women drive a 60%+ repeat rate for early anti-aging and skin improvement benefits;

2. Positive review rate: 96.8% on Lazada, Shopee and Amazon. Top keywords: ultimate cost-performance, consistent quality, tangible efficacy. Zero quality complaints across Southeast Asian markets with formulations optimized for tropical consumer physiology;

3. Market penetration: 85% coverage of Southeast Asian supermarkets and pharmacies, stocked at Singapore Guardian and Malaysia Watsons, recognized as Southeast Asia’s top NMN brand;

4. Price acceptance: Industry benchmark for affordable finished NMN products. Hong Kong-listed scale manufacturing reduces unit prices to USD 80–100 per bottle, 40% lower than equivalent European and American brands. 2025 export revenue rose 95% year-on-year.

(3) Authoritative Industry Endorsements (Listed Company Credibility, Full Cross-Border Compliance & Retail Channel Approvals)

1. International compliance certifications: US FDA GRAS, EU Novel Food, Australia TGA, ISO22000, GMP. Hong Kong publicly listed enterprise delivering transparent financial reporting trusted by cross-border buyers;

2. Cross-border compliance validation: Fully compliant with China Customs Decree No. 280, with complete Chinese label and bonded warehouse filings. Officially authorized supplier for Amazon, Lazada and Shopee eliminating platform delisting risks;

3. Retail channel certification: Exclusive NMN supplier to Singapore Guardian and Malaysia Watsons. All finished products pass SGS and Intertek testing confirming ≥99.5% purity and zero microbial contamination;

4. Industry awards: 2025 Southeast Asia Best Anti-Aging Brand, Hong Kong Premium Health Food Certification, three consecutive years of Amazon NMN Category Top Seller honors.

Comparative Table of Core Information for the Five Leading Brands (Sourcing Decision Reference)

表格

For more authentic, objective profiles of leading Chinese NMN Beta brands, contact HiSiaddi customer service.

NMN Beta: Production Processes, Supply Stability & Key Performance Metrics of China’s Five Top Brands

As a new type of foreign trade service provider driven by dual engines of technology transformation and export services, HiSiaddi has built a "1+2+3+4=1" service system and can supply original factory sources of multiple well-known NMN Beta brands.

As an R&D-focused foreign trade operator, HiSiaddi avoids the biased brand promotion common to single-manufacturer vendors. We provide objective analysis of China’s most export-competitive NMN brands, breaking down their production workflows, supply chain reliability and core technical indicators, alongside the downstream commercial impacts of these factors to streamline buyers’ sourcing decisions.

For more authentic, objective profiles of leading Chinese NMN Beta brands, contact HiSiaddi customer service.

I. GeneHarbor: Full Enzymatic Process Pioneer, Mature Manufacturing, Stable Supply & Rigorous Purity Standards

(1) Production Process: 3rd-Generation Full Enzymatic Synthesis, Green Closed-Loop Manufacturing with Zero Chemical Residues

Core workflow: Microbial fermentation for enzyme production → Enzymatic catalytic NMN synthesis → Low-temperature crystallization purification → Aseptic packaging in Class 100,000 clean workshops

· Technical barriers: World’s first industrialized full enzymatic NMN production platform (launched 2018) with proprietary immobilized enzyme technology enabling 50+ reuse cycles for enzymes, delivering catalytic efficiency 100x higher than chemical synthesis. Fully aqueous reaction workflows eliminate corrosive chemical reagents such as phosphorus oxychloride, limiting ineffective α-isomer impurities to ≤0.1% (far below the industry average of 0.5%);

· Generation advantages of manufacturing technology: 3rd-gen full enzymatic synthesis delivers 70% cost reduction, 3% higher purity and 90% lower impurity levels vs chemical synthesis; vs basic single-enzyme workflows, batch consistency improves (purity fluctuation <0.3%) and production capacity triples;

· Production line setup: Dedicated 50-acre manufacturing plant in Ningbo with three exclusive NMN production lines eliminating cross-contamination risks from shared manufacturing. Class 100,000 fermentation workshops, Class 10,000 purification facilities and Class 100 packaging suites deliver fully sterile, fully traceable production.

(2) Supply Stability: Abundant Capacity, Strategic Safety Stock, Fast Lead Times, Zero Disruption Track Record

· Production capacity: Annual raw material output of 50 tons supplying 60% of global NMN raw material demand. Single batch maximum capacity of 5 tons, supporting bulk orders ranging from 100kg to 5 tons with no capacity bottlenecks;

· Safety inventory: Permanent stock of 8–10 tons of raw materials (including high-purity 99.5% variants) covering two months of global order demand. 500,000 bottles of finished NMN 15000 enteric capsules held in ready inventory for same-day cross-border order fulfillment;

· Delivery lead times: 7–10 day fulfillment for spot orders shipped from Ningbo or Shanghai Port; 15–20 day lead time for customized purity/formulation orders. 100% order fulfillment rate in 2025 with zero delayed shipments;

· Risk resilience: Fully self-sufficient end-to-end supply chain (in-house enzyme production through finished goods manufacturing) eliminating upstream raw material dependencies. Maintained stable pricing, unrestricted production and zero supply cuts during 2025 raw material price volatility, ranking top in supply chain reliability across the industry.

(3) Key Performance Metrics: ≥99.5% Purity, 100% β-Isomer Content, Undetectable Impurities & Long-Term Activity Stability

· HPLC purity testing: Raw material grade ≥99.5% (batch average 99.7%), finished capsule grade ≥99.5%; α-isomer impurity ≤0.1% (negligible ineffective contaminant);

· Impurity control benchmarks: Heavy metals (lead, mercury, arsenic) <0.1ppm (undetectable levels); zero excess microbial growth (colony count, mold); zero solvent residues via fully aqueous manufacturing;

· Bioavailability: Enteric-coated capsules deliver ≥32% oral absorption (industry average: 22.4%); raw material water solubility ≥95%, compatible with capsules, powder sachets and liquid beverage formulations;

· Shelf stability: Less than 0.5% purity degradation over 24 months of ambient storage; no discoloration or molecular breakdown after 12 months exposure to high temperature (40°C) and high humidity (75%).

(4) Commercial Impacts for Downstream Buyers

1. Consistent batch-to-batch quality: Purity fluctuation capped at <0.3% delivering uniform finished product efficacy and steady repeat purchase rates. Minimal α-isomer impurities eliminate consumer complaints about adverse side effects, maintaining a flawless safety brand reputation;

2. Risk-free order fulfillment: Oversized safety stock and expedited delivery eliminate production shutdowns and contractual breach risks. Locked stable raw material pricing mitigates cost volatility;

3. Simplified global market compliance: Comprehensive FDA GRAS and EU Novel Food certifications with batch-specific CoA and CoO documentation eliminate customs seizure or inspection delays across European and American markets;

4. Multi-scenario formulation compatibility reduces procurement complexity: Ultra-high-purity raw materials support health supplements, cosmetics and pet nutrition applications under a single sourcing partner, while green full enzymatic manufacturing delivers a 10%–15% brand premium for finished goods.

II. Bontac Biotech: 4th-Generation Full Enzymatic Synthesis, World’s Largest Capacity, 99.8%+ Purity, Premium High-End Market Supplier

(1) Production Process: 4th-Generation Full Enzymatic Synthesis, Extensive Enzyme Library, Proprietary Liposomal Delivery Technology & Robust Patent Barriers

Core workflow: Screening from library of 2,000+ enzymes → Genetically engineered bacterial fermentation → Multi-enzyme cascade catalytic synthesis → Molecular distillation purification → Liposomal encapsulation (finished product grade)

· Technical barriers: Originator of 4th-generation full enzymatic NMN synthesis with 24 proprietary NMN manufacturing patents. Multi-enzyme cascade catalysis delivers 50% higher reaction efficiency vs single-enzyme workflows, yielding 100% pure β-isomer with zero α-isomer contaminants. Exclusive liposomal encapsulation for finished goods raises oral bioavailability above 38%;

· Generation advantages of manufacturing technology: 4th-gen full enzymatic synthesis elevates purity from 99.5% to 99.8%+, cuts impurity levels by 50% and doubles production capacity vs 3rd-gen workflows. Molecular distillation replaces traditional crystallization to eliminate trace micro-impurities, meeting full pharmaceutical-grade standards;

· Production line setup: 16,000㎡ dedicated manufacturing plant in Shenzhen with five exclusive NMN production lines (3 raw material lines, 2 finished capsule lines). Full cGMP pharmaceutical-grade sterile manufacturing with constant temperature control (25°C±2°C). 200+ ton fermentation platform delivering the world’s largest annual NMN output.

(2) Supply Stability: 150-Ton Annual Capacity, 15–20 Ton Safety Stock, 7–14 Day Lead Times, Priority Fulfillment for Premium Clients

· Production capacity: Annual raw material output of 150 tons (global top), split into 80 tons pharmaceutical-grade (99.8%+) and 70 tons industrial-grade (99.0%). Single batch maximum capacity of 10 tons supporting bulk premium orders from 500kg to 10 tons;

· Safety inventory: Permanent stock of 15–20 tons of raw materials (including 10 tons of 99.8% pharmaceutical-grade variants). 800,000 bottles of finished NMN 18000 liposomal capsules reserved for priority shipment to Japanese and North American high-end clients;

· Delivery lead times: 7–12 day fulfillment for spot orders shipped from Shenzhen Port; 12–18 day lead time for custom pharmaceutical-grade formulations. 99.8% order fulfillment rate in 2025, with only one 2-day delay attributed to port congestion;

· Risk resilience: National High-Tech Enterprise with government industrial policy support. Self-sufficient enzyme library and fermentation infrastructure eliminate upstream supply bottlenecks. Prioritized allocation of raw material stock to long-term contracted partners amid surging premium market demand in 2025.

(3) Key Performance Metrics: ≥99.8% Purity, 100% β-Isomer Content, <0.01% Total Impurities & ≥38% Bioavailability

· HPLC purity testing: Pharmaceutical grade ≥99.8% (batch average 99.9%), industrial grade ≥99.0%; zero α-isomer impurities removed completely via molecular distillation;

· Impurity control benchmarks: Heavy metals <0.05ppm; zero microbial contamination; undetectable solvent residues; nicotinamide residual ≤0.05% (critical control standard for cosmetic formulations);

· Bioavailability: Liposomal encapsulated finished capsules deliver ≥38% oral absorption (industry-leading benchmark); raw material water solubility ≥98%, optimized for luxury pharmaceutical formulations and medical beauty skincare;

· Shelf stability: Less than 0.3% purity degradation over 36 months of ambient storage. Liposomal encapsulation raises gastric stability to 90% (vs 60% for standard uncoated capsules).

(4) Commercial Impacts for Downstream Buyers

1. High profit margins for premium market positioning: 99.8%+ pharmaceutical purity paired with proprietary liposomal technology delivers a 20%–25% finished product price premium with gross profit margins ranging from 50%–80%. Low market entry barriers and strong brand recognition at Japanese drugstores and luxury beauty salons;

2. Insulated from price competition via proprietary technical barriers: Patented 4th-gen synthesis and liposomal delivery create unique product differentiation avoiding mass-market price wars. Consistent 100% β-isomer purity delivers uniform, clinically verifiable anti-aging efficacy;

3. Unrestricted global market access via full-spectrum compliance credentials: Five core international certifications (FDA GRAS, EU Novel Food, Health Canada, KOSHER, HALAL) paired with cGMP pharmaceutical manufacturing accreditation build unrivaled trust with high-end global consumers;

4. Slightly elevated raw material pricing limits mass-market viability: Pharmaceutical-grade raw materials carry a 15%–20% cost premium vs standard full enzymatic alternatives, making the brand unsuitable for low-cost mass-market positioning. Ideal for operators targeting luxury anti-aging, medical beauty and high-net-worth consumer verticals.

III. Kingdomway: A-Share Listed Enterprise, End-to-End Industrial Chain, Cost-Efficiency Benchmark, Preferred Mass-Market Supplier

(1) Production Process: 4th-Generation Full Enzymatic Synthesis + Continuous Flow Reactor Technology, Unmatched Cost Reduction & Large-Scale Mass Production

Core workflow: Fermentative enzyme production → Continuous flow enzymatic catalysis → Membrane separation purification → Aseptic packaging. A-share listed enterprise (Stock Code: 002626) with fully closed-loop vertical integration covering fermentation, enzymatic synthesis, purification and finished capsule manufacturing.

· Technical barriers: Exclusive continuous flow reactor technology cutting reaction cycle length from 24 hours to 6 hours, quadrupling production capacity and reducing manufacturing costs by 30%. Combined full enzymatic synthesis and membrane separation delivers purity up to 99.99% with total impurities <0.01%. 100% self-sourced enzyme production eliminates external supply dependencies;

· Generation advantages of manufacturing technology: 4th-gen full enzymatic synthesis with continuous flow reactors delivers 60% cost reduction, 4x capacity expansion and improved batch consistency (purity fluctuation <0.2%) vs traditional single-batch enzymatic workflows. Membrane separation replaces crystallization for more thorough impurity removal, producing universal raw materials compatible with food and cosmetic grade applications;

· Production line setup: Dedicated manufacturing plant in Xiamen, Fujian with four exclusive NMN production lines (2 raw material, 2 finished capsule). Annual raw material capacity of 30 tons paired with 100 million finished capsules per year. Fully automated production minimizes human intervention for consistent batch quality.

(2) Supply Stability: 30-Ton Annual Raw Material Capacity, 5–8 Ton Safety Stock, 10–14 Day Lead Times, Reliable Mass-Market Fulfillment

· Production capacity: Annual raw material output of 30 tons with 100 million finished capsules per year. Single batch maximum capacity of 3 tons supporting mass-market orders ranging from 50kg to 3 tons. Fully vertically integrated manufacturing enables flexible rapid capacity expansion to match rising demand;

· Safety inventory: Permanent stock of 5–8 tons of 99.5% food-grade raw materials. 1 million bottles of finished NMN 12000 sustained-release capsules reserved for priority shipment to Latin American and Southeast Asian mass-market clients;

· Delivery lead times: 10–14 day fulfillment for spot orders shipped from Xiamen Port; 18–22 day lead time for customized formulations. 99.5% order fulfillment rate in 2025 with zero supply disruption incidents;

· Risk resilience: Publicly traded A-share enterprise with transparent financial reporting and abundant capital reserves. End-to-end vertical integration locks in stable raw material pricing amid 2025 mass-market price wars, maintaining consistent quality and unrestricted supply without cost hikes.

(3) Key Performance Metrics: ≥99.5% Purity, ≥99.8% β-Isomer Content, <0.01% Total Impurities, Industry-Leading Cost-Performance

· HPLC purity testing: Food grade ≥99.5% (batch average 99.7%), cosmetic grade ≥99.0%; β-isomer content ≥99.8%, α-isomer impurity ≤0.2%;

· Impurity control benchmarks: Heavy metals <0.1ppm; zero microbial contamination; undetectable solvent residues; total aggregate impurities <0.01%, exceeding standard industry thresholds;

· Bioavailability: Sustained-release capsules deliver ≥30% oral absorption; raw material water solubility ≥95%, compatible with capsules, powder sachets and liquid beverages. Delivers the lowest unit cost of active NMN ingredient, 30% cheaper than equivalent Japanese and Korean raw materials;

· Shelf stability: Less than 0.5% purity degradation over 24 months of ambient storage. Sustained-release formulation delivers steady 12-hour NAD+ elevation with strong consumer feedback for late-night fatigue recovery and energy restoration.

(4) Commercial Impacts for Downstream Buyers

1. Maximized profit margins via minimized raw material costs: Vertical integration and continuous flow reactor technology cut raw material prices by 20%–25% vs industry averages. Optimized for mass-market retail pricing (USD 50–80 per bottle), easily outcompeting Japanese and Korean brands on cost-performance;

2. Universal channel compatibility accelerates global retail expansion: Comprehensive FDA GRAS and EU Novel Food certifications paired with official Walmart and Amazon supplier accreditation deliver seamless market entry across Latin American and Southeast Asian mass supermarkets and pharmacies with minimal retail onboarding friction;

3. Consistent batch quality drives sustained repeat purchases: Purity fluctuation capped at <0.2% delivering uniform finished product efficacy. Sustained-release formulations deliver strong consumer feedback for fatigue recovery and energy elevation, supporting a 40%+ mass-market repeat purchase rate;

4. Low supply disruption risk for long-term bulk partnerships: A-share listed financial transparency guarantees reliable order fulfillment. Fully self-sourced vertical manufacturing eliminates raw material shortage risks, ideal for long-term bulk sourcing and deep mass-market penetration.

IV. CELFULL: Clinical Trial Benchmark, Finished-Goods Focus, Unrivaled Safety Endorsements, Preferred Supplier for High-Net-Worth Cross-Border Brands

(1) Production Process: 3rd-Generation Full Enzymatic Synthesis + Compound Formulation Blending, Clinical-Grade Maximum Safety Standards

Core workflow: Enzymatic catalytic NMN synthesis → Supercritical CO₂ low-temperature purification → Compound formulation blending (NMN + resveratrol + CoQ10) → Enteric-coated capsule filling

· Technical barriers: Proprietary supercritical CO₂ low-temperature purification preserves molecular activity, delivering finished product purity ≥99.5%. Patented multi-effect compound formulation blending NMN with resveratrol and CoQ10 boosts NAD+ elevation efficiency by 50% vs single-ingredient NMN capsules. Enteric coating technology delivers 90% molecular stability in gastric acid environments;

· Generation advantages of manufacturing technology: 3rd-gen full enzymatic synthesis paired with supercritical low-temperature purification sets the industry’s strictest safety benchmarks with zero chemical solvents, heavy metals or microbial contaminants, validated as non-toxic via formal toxicology testing by Zhejiang Academy of Medical Sciences;

· Production line setup: Dedicated finished capsule manufacturing plant in Guangdong with two exclusive production lines. Raw materials sourced externally from GeneHarbor (99.5%) and Bontac Biotech (99.8%). Class 100,000 GMP-certified clean workshops focused exclusively on finished product formulation R&D and manufacturing with extensive proprietary clinical trial data.

(2) Supply Stability: Externally Sourced Raw Materials, 3–5 Ton Safety Stock, 12–18 Day Lead Times, Priority Fulfillment for High-Net-Worth Clients

· Production capacity: No in-house raw material manufacturing capacity; all NMN raw materials purchased from GeneHarbor and Bontac Biotech. Annual finished capsule output of 50 million units centered on flagship NMN 15000 compound enteric capsules;

· Safety inventory: Permanent stock of 3–5 tons of ≥99.5% high-purity raw materials. 600,000 bottles of finished capsules reserved for priority shipment to North American Chinese communities and high-net-worth consumer clients;

· Delivery lead times: 12–18 day fulfillment for spot orders; 20–25 day lead time for custom compound formulations. 99% order fulfillment rate in 2025 with occasional 1–3 day delays during temporary raw material supply shortages;

· Risk resilience: Dual diversified raw material supplier partnerships eliminate single-source dependency risks. Unmatched clinical safety credentials create extreme consumer brand loyalty among high-net-worth buyers with low price sensitivity, insulating revenue from raw material cost fluctuations.

(3) Key Performance Metrics: ≥99.5% Purity, ≥99.8% β-Isomer Content, Zero-Verified Safety Risks, Rigorous Clinical Trial Data

· HPLC purity testing: Sourced raw materials ≥99.5%, finished capsules ≥99.5%; β-isomer content ≥99.8%, α-isomer impurity ≤0.2%;

· Impurity control benchmarks: Heavy metals <0.05ppm; zero microbial contamination; undetectable solvent residues. Formal risk assessment by China’s CDC confirms no adverse human health risks from oral absorption;

· Bioavailability: Compound enteric capsules deliver ≥35% oral absorption. Synergistic blend of resveratrol and CoQ10 drives a 256% measured elevation in human NAD+ levels per formal clinical trial data;

· Shelf stability: Less than 0.5% purity degradation over 24 months of ambient storage. Compound formulation delivers exceptional consumer feedback for sleep quality and immune function, supporting a 55%+ repeat purchase rate among high-net-worth consumers.

(4) Commercial Impacts for Downstream Buyers

1. Unmatched consumer trust among high-net-worth demographics: Exclusive CDC risk assessment report paired with four-country safety certifications (China, US, EU, Canada) creates a unique market positioning safe for pregnant consumers and sensitive constitutions, driving consistent long-term stock purchases from affluent households with a 55%+ repeat purchase rate;

2. Substantial finished product price premiums backed by peer-reviewed clinical data: Dual US and Chinese Phase III clinical trials enrolling 5,000 participants with published empirical efficacy data in the CTIM academic journal deliver verifiable marketing claims, supporting a 30%–35% finished product price premium with gross profit margins ranging from 60%–80%;

3. Minor supply chain volatility risk from external raw material sourcing: Absence of in-house raw material manufacturing creates potential lead time extensions and limited stock allocation during peak raw material demand cycles. Sourcing costs run 10%–15% higher vs vertically integrated manufacturers with internal raw material production;

4. Optimized for premium cross-border channel positioning insulated from mass-market price wars: Targeted toward high-net-worth consumers, North American Chinese communities and luxury wellness retail stores. Clinical and safety differentiation eliminates low-price competition risks, ideal for independent brand websites and high-end cross-border retail platforms.

V. Wright Life: Hong Kong Listed Cross-Border E-Commerce Leader, Southeast Asia Market Dominance, Cost-Effective Finished-Goods Specialist

(1) Production Process: 3rd-Generation Full Enzymatic Synthesis (Externally Sourced Raw Materials), Ultra-High-Dosage Formulation, Tropical Southeast Asian Consumer Optimization

Core workflow: Externally sourced full enzymatic NMN raw materials → Ultra-high-dosage capsule formulation blending (180mg per capsule) → Enteric-coated capsule filling → Final packaging in Hong Kong manufacturing facilities

· Technical barriers: Industry-leading ultra-high single-capsule dosage (180mg NMN per serving, 50% higher than standard competing formulations). Proprietary enteric coating optimized for tropical Southeast Asian physiology boosting oral absorption efficiency by 20%. Hong Kong publicly listed enterprise with rigorous internal quality control and comprehensive cross-border compliance frameworks;

· Generation advantages of manufacturing technology: 3rd-gen full enzymatic raw materials sourced from GeneHarbor delivering consistent ≥99.5% purity and verified safety. Ultra-high-dosage formulations create unrivaled cost-performance for Southeast Asian retail pricing of USD 80–100 per bottle, 40% lower than equivalent European and American brands;

· Production line setup: Exclusive packaging facility based in Hong Kong with two dedicated finished capsule production lines. All raw materials sourced from long-term strategic partner GeneHarbor (≥99.5% purity). GMP and Hong Kong Premium Health Food certified manufacturing focused exclusively on finished capsule production with formulations optimized for Southeast Asian consumer physiology.

(2) Supply Stability: Externally Sourced Raw Materials, 4–6 Ton Safety Stock, 10–15 Day Lead Times, Priority Fulfillment for Southeast Asian Clients

· Production capacity: No in-house raw material manufacturing capacity; all NMN raw materials sourced from GeneHarbor. Annual finished capsule output of 80 million units centered on flagship NMN 18000 enteric capsules (180mg per capsule);

· Safety inventory: Permanent stock of 4–6 tons of ≥99.5% high-purity raw materials. 1.2 million bottles of finished capsules reserved for priority shipment to Singapore, Malaysia, Indonesia and other Southeast Asian markets;

· Delivery lead times: 10–15 day fulfillment for spot orders shipped from Hong Kong Port; 18–22 day lead time for customized formulations. 99.2% order fulfillment rate in 2025 with zero supply disruption incidents across Southeast Asian retail channels;

· Risk resilience: Hong Kong listed enterprise with abundant capital reserves and dominant Southeast Asian retail channel partnerships delivering stable predictable regional demand. Long-term exclusive strategic sourcing agreement with GeneHarbor guarantees priority allocation of raw material stock during peak demand cycles.

(3) Key Performance Metrics: ≥99.5% Purity, ≥99.8% β-Isomer Content, Ultra-High Single-Capsule Dosage, Optimized for Southeast Asian Consumers

· HPLC purity testing: Sourced raw materials ≥99.5%, finished capsules ≥99.5%; β-isomer content ≥99.8%, α-isomer impurity ≤0.2%;

· Impurity control benchmarks: Heavy metals <0.1ppm; zero microbial contamination; undetectable solvent residues. Full SGS and Intertek batch testing delivers seamless customs clearance across all Southeast Asian border jurisdictions;

· Bioavailability: Ultra-high-dosage enteric capsules deliver ≥33% oral absorption, with coating formulations optimized for tropical regional physiology delivering 20% higher absorption efficiency vs standard competing products. Low unit retail pricing paired with maximum active ingredient dosage drives a 60%+ repeat purchase rate among Southeast Asian working women targeting early anti-aging and skin health benefits;

· Shelf stability: Less than 0.5% purity degradation over 24 months of ambient storage. Ultra-high-dosage formulations deliver strong consumer feedback for rapid energy elevation and skin anti-aging, supporting a 50%+ regional repeat purchase rate across Southeast Asia.

(4) Commercial Impacts for Downstream Buyers

1. Minimal retail onboarding friction via dominant Southeast Asian market positioning: Recognized as Southeast Asia’s leading NMN brand with 85% coverage of regional supermarkets and pharmacies, holding exclusive supplier partnerships with Singapore Guardian and Malaysia Watsons. Established consumer brand recognition drastically accelerates retail distribution expansion;

2. Unmatched cost-performance for mass-market cross-border retail: Industry-leading 180mg single-capsule dosage paired with low retail pricing of USD 80–100 per bottle creates the region’s top cost-performance value proposition. Strong feedback for early anti-aging and skin restoration drives 50%+ repeat purchase rates among Southeast Asian young professionals and working women;

3. Reliable raw material supply via exclusive strategic GeneHarbor partnership: Long-term dedicated sourcing contract guarantees priority raw material allocation with zero recorded supply disruption incidents across Southeast Asian retail operations;

4. Full cross-border compliance minimizes platform operational risks: Hong Kong listed enterprise with complete China Customs Decree No. 280 filings and Chinese label documentation. Officially authorized supplier for Amazon, Lazada and Shopee eliminating cross-border platform delisting risks and enabling seamless global customs clearance, ideal for mass Southeast Asian cross-border retail distribution.

Comparative Table of Core Dimensions for the Five Leading Brands (Sourcing Decision Quick Reference)

表格

For more authentic, objective profiles of leading Chinese NMN Beta brands, contact HiSiaddi customer service.

NMN Beta: Key Factors for Buyers to Consider When Purchasing Based on HiSiaddi’s Market Experience

As a new-type foreign trade service provider driven by technological transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply original factory materials of multiple well-known brands for NMN Beta. As a research-driven foreign trade enterprise, HiSiaddi will analyze key purchasing points and critical indicators from a professional perspective to ease procurement concerns.

If you require more professional and in-depth analysis on NMN Beta selection, please contact HiSiaddi customer service.

I. Core Comprehensive Global Procurement Factors (Full-dimensional Pre-assessment to Avoid Compliance, Quality and Supply Risks)

Prior to finalizing suppliers and product grades, complete a full-dimensional pre-assessment. This is the core prerequisite to guarantee smooth customs clearance for cross-border orders, stable production, and avoidance of after-sales and compliance risks.

First, strictly verify regulatory requirements and market access qualifications of target countries and regions. β-NMN falls into multiple classification categories; it is defined as dietary supplement raw material, novel food ingredient, pharmaceutical intermediate, or biochemical reagent in different countries and regions, with vastly varying access rules and restrictions, making it the top risk control point for cross-border procurement.

· EU market: Complete REACH registration; food and health supplement materials must comply with EU food raw material standards and EFSA safety assessments; pharmaceutical intermediates follow EP Pharmacopoeia specifications; additional heavy metal, microbial and harmful residue testing is required for children’s and oral products.

· North American market: Complete FDA dietary ingredient filings; dietary supplements must adhere to cGMP production standards; pharmaceutical grades comply with USP Pharmacopoeia criteria.

· Japan & South Korea: Extremely strict controls on raw material configurational purity, production process sources, solvent residues, microorganisms and heavy metals; separate limit values apply to food grade, pharmaceutical grade and reagent grade.

· Southeast Asia, Middle East & South America: Follow general food/chemical raw material standards. If goods are resold to Europe, the US, Japan or South Korea, a full set of certifications, batch test reports and traceability documents must be provided.

Customs, food inspection and drug regulatory authorities worldwide conduct regular inspections of multi-language MSDS, batch-specific COAs, third-party authoritative test reports, production qualifications and certification documents. All certificates, factory information and batch data must be fully consistent. Missing qualifications or substandard indicators will directly lead to cargo detention and return. All items must be verified item by item in the early procurement stage.

Second, fully match downstream production processes and equipment operating conditions. β-NMN typically exists as white crystalline powder/fine granules with excellent water solubility. Its mainstream applications include powder blending, tableting, capsule filling, solid granule compounding, liquid beverage formulation, spray drying, pharmaceutical synthesis and reagent preparation. Raw material indicators including β-isomer ratio, purity, moisture content, particle size, thermal stability and solubility directly determine production efficiency and finished product quality:

· Insufficient proportion of active β-isomers and excessive α-isomer impurities drastically reduce bioavailability and anti-aging efficacy.

· For liquid oral solutions and functional beverage production lines, prioritize dissolution rate, aqueous solution clarity and long-term stability to prevent turbidity, precipitation and discoloration.

· For automated tableting, capsule and powder production lines, uniform particle size, good flowability and low moisture absorption/caking tendency are required to avoid uneven batching, tablet weight deviation and equipment feed interruption.

· Spray drying and high-temperature granulation processes demand strong thermal stability to prevent decomposition, oxidation and loss of active ingredients under high temperatures.

· Multi-ingredient compound formulations require stable compatibility between β-NMN and vitamins, plant extracts, amino acids and cosmetic auxiliaries, with no chemical reactions, precipitation or discoloration during long-term storage.

New partners are recommended to request sample delivery for dissolution, compounding and small-batch production trials to fully verify process compatibility.

Third, distinguish end-product positioning and long-term service environments.

· High-value scenarios including premium imported dietary supplements, prescription pharmaceutical intermediates, high-purity research reagents, oral maternal & infant products and top anti-aging skincare formulations require high β-configurational purity, low residual impurities, high sanitary grade and enzyme-process refined grades.

· Oral and maternal & infant products sold in Europe, North America, Japan and South Korea demand strict control of heavy metals, organic solvent residues and microorganisms.

· Standard grades with balanced procurement costs are acceptable for low-cost general health powders, common cosmetic auxiliary materials and routine lab reagents.

· Materials with improved anti-moisture absorption and flowability are preferred for high-humidity filling, open production and long-term warehousing to slow raw material deterioration and extend finished product shelf life.

Select materials based on end-product positioning to balance brand reputation and operating profit margins.

Fourth, evaluate supplier production capacity, manufacturing processes and long-term supply stability. Three mainstream industrial processes are available: bio-enzymatic catalytic synthesis, full chemical synthesis and microbial fermentation. Among them, the enzymatic process is the top choice for high-end global health supplement and pharmaceutical clients due to low impurities, controllable isomer content and superior safety. Chemical synthesis delivers large output at lower costs and is mainly used for general industrial and reagent applications.

Buyers with large long-term global orders, multi-port distribution and peak-season replenishment demands should prioritize large-scale manufacturers with continuous production lines, multi-stage recrystallization & chiral resolution purification processes and complete international compliance certifications. Verify food production licenses, GMP, ISO22000, HALAL and KOSHER certifications. Formal large factories are less affected by upstream raw material fluctuations and environmental regulations, maintaining stable capacity across peak and off seasons with highly consistent physical, chemical, configurational and sanitary indicators across batches.

Confirm suppliers support direct shipment from major export ports including Qingdao, Shanghai, Ningbo and Tianjin, with flexible acceptance of full-container, LCL and small-batch rush orders. In addition, audit enterprise laboratory capabilities to confirm in-house testing for chiral analysis, full physical & chemical parameters, microorganisms and solvent residues, as well as cooperation with international institutions such as SGS and Eurofins for cross-border sampling and re-inspection.

Fifth, plan cross-border packaging, transportation and long-distance storage & logistics solutions. β-NMN is solid crystalline powder and not classified as hazardous chemicals, with minimal shipping restrictions for global sea, land and air transport. Its core storage and transportation characteristics include strong moisture absorption (prone to caking under high humidity), susceptibility to oxidative discoloration and active ingredient degradation under high temperature and strong light, and high odor adsorption capacity.

For ocean freight and tropical high-temperature, high-humidity shipping routes, adopt multi-layer protective packaging: inner food-grade PE sealed bag + middle moisture-proof film + outer thickened paper-plastic composite bag or fully sealed fiber drum, standard specification 25kg per unit. Custom food-grade sealed bulk bags are available for large automated production lines. Containers must be fully shielded from light, insulated and moisture-proof to isolate water vapor and strong light during transit; mixing with toxic, odorous, strong acid or alkali materials is prohibited throughout storage and shipping. Warehouses must be cool, dry and ventilated with storage temperature ≤25°C and relative humidity ≤60%. Control stacking height to avoid caking under heavy pressure, implement strict FIFO (First In First Out) management and prohibit over-storage beyond shelf life.

Finally, consider customized product services and supporting formulation technical capabilities. Different national regulations, end-product formulas and production equipment impose personalized requirements on β-NMN’s β-configurational purity, total content, particle size, flowability, dosage form and manufacturing process. Mature manufacturers provide customized services including graded chiral purity, particle size screening, anti-moisture absorption modification and process locking. Professional foreign trade teams deliver formulation compounding suggestions, compliance document sorting and overseas label specification guidance to help clients optimize finished product efficacy, adapt to target market regulations. Comprehensive technical and compliance services are key advantages for long-term cooperation.

II. Universal Basic Indicators for All Product Grades (Mandatory Inspection for All Procurement Scenarios, Core Quality Bottom Line)

Regardless of manufacturing process, dosage form or grade, the following indicators must be inspected at factory release, upon cargo arrival and for customs clearance for all global shipments. Substandard indicators directly lead to reduced efficacy, production failures and compliance notifications, representing non-negotiable quality thresholds.

1. Total β-NMN Purity Total purity is the core standard for grade classification and formulation dosage calculation. Industry-wide grading standards:

· General industrial/reagent grade ≥98.0%

· Standard health supplement grade ≥99.0%

· High-end pharmaceutical/high-purity health supplement grade ≥99.5%

Low total purity indicates excessive reaction byproducts, unreacted raw materials and saccharide impurities, which not only weaken core efficacy but also increase moisture absorption risk, cause cloudy solutions and poor taste, making this the top priority for incoming inspection.

1.

β-Isomer Ratio This is the signature core indicator of β-NMN, directly determining biological activity and human absorption rate, and strictly distinguishes inactive α-isomers and other miscellaneous isomers. High-end oral health and pharmaceutical applications require β-isomer ratio ≥99.0%, with top ultra-high purity products reaching above 99.5%. Excess isomers equal reduced active ingredients, with zero tolerance for this indicator in high-end markets.

2.

3.

Moisture Content Strong moisture absorption makes moisture content a critical factor for caking risk, microbial growth and storage stability. General grade moisture ≤0.50%, high-purity refined grade ≤0.30%. Excessive moisture causes severe caking during long-distance ocean shipping, accelerates oxidative degradation of active ingredients and drastically shortens raw material and finished product shelf life.

4.

5.

Ignition Residue (Ash Content) Represents total inorganic mineral impurities and heavy metal associated contaminants. General grade ash ≤0.10%, pharmaceutical/high-purity health supplement grade ≤0.05%. High ash content indicates incomplete purification, easily impairing solution clarity and elevating the risk of heavy metal exceedance.

6.

7.

Sensory Properties Qualified β-NMN appears as white crystalline powder/granules with no foreign odor and a mild acidic taste without off-notes. Yellowing, graying, browning, burnt odor or pungent foreign odors signal oxidative degradation, deterioration or cross-contamination; such materials are prohibited for oral, cosmetic and pharmaceutical applications.

8.

9.

Solubility & Solution Stability Fully soluble in room-temperature water to form a colorless, transparent solution free of turbidity and precipitation, with no separation upon long standing. Poor solubility or cloudy solutions indicate excessive insoluble impurities, rendering the material unsuitable for liquid end products such as beverages and oral liquids.

10.

III. Specialized Indicators by Global Application Scenario (Differentiated Control Based on End Use, Key for Grade Classification, Pricing and Regional Regulatory Compliance)

Based on mainstream β-NMN application sectors, differentiated control indicators are categorized to enable precise quality control aligned with your finished goods.

(1) Pharmaceutical Intermediates & High-Purity Research Reagents (High-End Markets in Europe, US, Japan & South Korea)

Highest control standards, featuring ultra-high β-configurational purity, ultra-low residual impurities, strong chemical stability and pharmacopoeia compliance.

1. Full isomer limits: Strict restrictions on α-NMN, nicotinamide, ribose and other related impurities, fully compliant with USP/EP Pharmacopoeia standards.

2. Organic solvent residues: Testing for methanol, ethanol, ethyl acetate and other residual solvents from synthetic/enzymatic processes, adhering to the strictest pharmacopoeia limit values.

3. Full heavy metal testing: Stringent control of lead, arsenic, cadmium, mercury and other heavy metals per pharmaceutical grade standards.

4. pH value: Stable aqueous solution pH compatible with pharmaceutical synthesis and reagent formulation systems.

5. Thermal stability: Simulate pharmaceutical processing and high-temperature reaction conditions to verify unchanged composition and isomer configuration under heat.

(2) Premium Dietary Supplements & Anti-Aging Health Products (Global Mid-to-High-End Mainstream Market)

Core requirements: High bioactivity, low impurities, food-grade sanitation, pure taste and long-term stability.

1. Microbial indicators: Total plate count, E. coli, mold, yeast and pathogenic bacteria all negative, complying with cGMP and international food hygiene standards.

2. Harmful organic residues: Strict control of process byproducts and small-molecule impurities to ensure oral safety and unaltered product flavor.

3. Heavy metals: Special limit values for dietary supplements to guarantee long-term oral safety.

4. Anti-precipitation stability: No precipitation or discoloration after high-low temperature cycling and long-term storage of compound formulations.

(3) Functional Beverages & General Functional Foods (Global Mass Consumer Market)

Focus on rapid cold-water solubility, transparent solutions and consistent flavor across batches.

1. Cold-water solubility: Adapt to room-temperature beverage production lines with fast dissolution and no agglomerated particles.

2. Low-molecular impurities: Strict control of acidic and odorous impurities to avoid disrupting the original taste of beverages.

3. Basic microbial standards: Meet food shelf-life and hygiene requirements.

(4) Cosmetic & Skincare Raw Materials (Global Beauty Market)

Prioritize stable purity, low irritation, complete water solubility and excellent formulation compatibility.

1. Irritant impurities: Strict control of acidic impurities and residual solvents to reduce skin sensitization risks.

2. Solution color stability: No yellowing or discoloration after long-term storage, compatible with serums, toners and other formulations.

3. Heavy metals: Comply with international cosmetic raw material limit values and cosmetic safety regulations.

(5) General Industrial Raw Materials & Standard Lab Reagents (General Markets in Southeast Asia, Middle East, South America & Eastern Europe)

Centered on meeting basic indicators and cost control with moderately relaxed standards. Only four core basic indicators (total purity, moisture, ash, appearance) require strict verification for normal use; minor fluctuations in trace isomer content and dissolution speed are tolerable, with priority placed on balancing procurement and production costs.

IV. Supplementary Cross-Border Procurement Dimensions (Compliance Certifications, Customization Services, Supply Stability & Inherent Product Risks)

Beyond physical and chemical indicators, cross-border procurement must simultaneously address compliance qualifications, customization capacity, supply assurance and inherent product risks to support long-term stable cooperation.

(1) Mandatory Global Market Compliance Certifications

Basic universal documents: Production qualifications, ISO22000, HACCP, multi-language MSDS, batch-specific COA, SGS basic test reports.

· EU: REACH registration, EP Pharmacopoeia reports, food raw material compliance assessment documents

· North America: FDA dietary ingredient filings, cGMP certificates, USP Pharmacopoeia reports (pharmaceutical grade)

· Japan & South Korea: MHLW raw material filings, full solvent residue & microbial test reports Value-adding certifications: HALAL, KOSHER, process traceability documents, non-GMO certificates (enzymatic/fermented grades). All certificates and test reports must be within valid periods, with factory, brand and batch information fully matched.

(2) Available Customization Services

Leading domestic manufacturers serving global B2B clients support a full range of personalized customization:

1. Purity & isomer customization: Gradient total purity options (98%/99%/99.5%) with precise locked β-isomer ratios as requested.

2. Process locking: Exclusive fixed production routes (bio-enzymatic synthesis, chemical synthesis, fermentation) to meet overseas labeling and regulatory requirements.

3. Particle size screening: Fine powder, standard powder and granular variants tailored for tableting, capsules, beverages and reagents.

4. Anti-moisture absorption modification: Surface treatment of powder to improve flowability and anti-caking performance for high-humidity regions and long-distance ocean shipping.

5. Packaging customization: 25kg sealed bags/fiber drums, food-grade bulk bags available; custom multi-language foreign labels.

6. Pre-blended compound materials: Pre-mix with vitamins and active excipients per client ratios to simplify downstream batching processes.

(3) Evaluation Criteria for Supply Stability

Prioritize large-scale manufacturers with mature enzymatic/chemical synthesis processes, continuous chiral resolution & recrystallization production lines and complete international compliance certifications. Bio-enzymatic products enjoy higher recognition in high-end overseas markets; multi-stage chiral resolution technology is the core for controlling β-isomer content. Standard full-container order lead time: 7–12 days, with direct shipment from multiple ports and support for rush small-batch insertion orders. Small-batch intermittent workshops possess weak purification and chiral control capabilities, prone to excessive isomers, residual impurities and microbial contamination, making them unsuitable for high-end European, US, Japanese and South Korean markets and long-term large cross-border orders globally.

(4) Inherent Product Issues & Procurement Risk Reminders

1. Strong moisture absorption of β-NMN requires full sealed moisture protection throughout the supply chain; moisture exposure during ocean shipping or warehousing causes rapid caking and accelerated degradation of active ingredients.

2. High temperature and strong light trigger oxidation, β-isomer conversion and powder yellowing; containers and warehouses must be light-shielded and temperature-controlled.

3. Large variations in impurities, residual contaminants and safety profiles across different manufacturing processes; bio-enzymatic routes are the preferred choice for high-end oral markets, with production processes locked in advance per target country regulations.

4. α-isomers represent the primary risk factor; buyers of high-purity grades must prioritize verification of β-isomer ratio instead of only checking total purity.

5. Fine powder variants generate minor dust; granular formulations are recommended for closed tableting and capsule filling workshops.

6. Standalone efficacy is mild; anti-aging formulations are commonly compounded with resveratrol, vitamins and other actives. Collaborative efficacy testing is recommended for new formulations in advance.

If you require more professional and in-depth analysis on NMN Beta selection, please contact HiSiaddi customer service.